Karyopharm Therapeutics Inc (KPTI) — Free Cash Flow Generation Index
Latest as of December 2021:
0.99x
Karyopharm Therapeutics Inc (KPTI) has a Free Cash Flow Generation Index of 0.99x as of December 2021. Free cash flow of $25.27 Million represents 1% of operating cash flow ($25.48 Million). Read Karyopharm Therapeutics Inc total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
0.99x
Free Cash Flow / Operating CF
Free Cash Flow
$25.27 Million
USD
Operating Cash Flow
$25.48 Million
USD
Capital Expenditures
$207.00K
USD
Annual Free Cash Flow Generation for Karyopharm Therapeutics Inc (None–None)
Year-by-year Free Cash Flow Generation Index for Karyopharm Therapeutics Inc. For the full company profile including market capitalisation, see Karyopharm Therapeutics Inc market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).